The notices it replaced
- Reissues: PAR-20-305 Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required)
- 2 steps back: PAR-18-313 Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50)
- 3 steps back: PAR-14-353 Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2015 and 2016 (P50)
- 4 steps back: PAR-14-031 Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2013 and 2014 (P50)
- 5 steps back: PAR-12-296 Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2013 and 2014 (P50)
- 6 steps back: PAR-10-003 Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2010, 2011 and 2012 (P50)
- 7 steps back: PAR-08-020 Specialized Programs of Research Excellence (SPOREs) in Human Cancer for the Year 2008 and 2009 (P50)
Replaced by PAR-28-022.
Who won it before
123 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $271,145,514 in first-year total cost, median $2,185,934.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RPRB-7 (M1)]19
- Special Emphasis Panel[ZCA1 RPRB-N (M1)]13
- Special Emphasis Panel[ZCA1 RPRB-8 (M1)]9
- Special Emphasis Panel[ZCA1 RPRB-0 (M1)]8
- Special Emphasis Panel[ZCA1 RPRB-6 (M1)]7
Most frequent institutions
- UNIVERSITY OF TX MD ANDERSON CAN CTR11
- SLOAN-KETTERING INST CAN RESEARCH10
- JOHNS HOPKINS UNIVERSITY8
- DANA-FARBER CANCER INST7
- MAYO CLINIC ROCHESTER7
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Dana Farber/Harvard Cancer Center Specialized Program of Research Excellence in Breast Cancer2P50CA168504-11 | ELLISEN, LEIF WLIN, NANCY UPOLYAK, KORNELIASHAPIRO, GEOFFREY I. | DANA-FARBER CANCER INST, MA | $2,607,297 | ZCA1 |
| 2025 | UT Southwestern Liver Cancer SPORE1P50CA295495-01A1 | HOSHIDA, YUJINSINGAL, AMIT | UT SOUTHWESTERN MEDICAL CENTER, TX | $2,513,300 | ZCA1 |
| 2025 | Fred Hutchinson Cancer Center Lung SPORE2P50CA228944-07A1 | HOUGHTON, A MCGARRY | FRED HUTCHINSON CANCER CENTER, WA | $2,471,718 | ZCA1 |
| 2025 | Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer2P50CA236733-06A1 | COFFEY, ROBERT J. | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $2,398,107 | ZCA1 |
| 2025 | Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer2P50CA196530-11 | HERBST, ROY SPOLITI, KATERINA ABIGAIL | YALE UNIVERSITY, CT | $2,341,652 | ZCA1 |
| 2025 | Michigan Prostate SPORE 2025-20302P50CA186786-11A1 | CHINNAIYAN, ARUL MPALAPATTU, GANESH S | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $2,303,511 | ZCA1 |
| 2025 | Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer1P50CA302572-01 | HOWE, JAMES RMENDA, YUSUFQUELLE, DAWN E | UNIVERSITY OF IOWA, IA | $2,185,934 | ZCA1 |
| 2025 | MD Anderson Sarcoma SPORE1P50CA302482-01 | FUTREAL, PHILLIP ANDREWGORLICK, RICHARD G. | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $1,824,620 | ZCA1 |
| 2024 | Translational Research Program in Cancer Differences across Populations1P50CA285275-01A1 · under PAR-20-305 | LI, CHRISTOPHER IPETERS, ULRIKETHOMAS, TIMOTHY K | FRED HUTCHINSON CANCER CENTER, WA | $2,575,782 | ZCA1 |
| 2024 | Targeted Therapies for Glioma2P50CA165962-11 · under PAR-20-305 | BATCHELOR, TRACY T | BRIGHAM AND WOMEN'S HOSPITAL, MA | $2,539,918 | ZCA1 |
| 2024 | SPORE in Ovarian Cancer2P50CA228991-06A1 · under PAR-20-305 | DRAPKIN, RONNY ISHIH, IE-MING | JOHNS HOPKINS UNIVERSITY, MD | $2,496,726 | ZCA1 |
| 2024 | SPORE in Soft Tissue Sarcoma2P50CA217694-06A1 · under PAR-20-305 | SINGER, SAMUEL | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,375,406 | ZCA1 |
| 2024 | SPORE in Breast Cancer2P50CA058223-29A1 · under PAR-20-305 | CAREY, LISA APEROU, CHARLES M | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $2,268,690 | ZCA1 |
| 2024 | Mayo Clinic Hepatobiliary SPORE2P50CA210964-06A1 · under PAR-20-305 | MC NIVEN, MARK A.ROBERTS, LEWIS R | MAYO CLINIC ROCHESTER, MN | $2,236,005 | ZCA1 |
| 2024 | UCSF Specialized Programs of Research Excellence (SPOREs) in Prostate Cancer1P50CA275741-01A1 · under PAR-20-305 | FENG, FELIX YI-CHUNGSMALL, ERIC J | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,204,158 | ZCA1 |
| 2024 | SPORE in Prostate Cancer1P50CA272391-01A1 · under PAR-20-305 | DENMEADE, SAMUEL RLUPOLD, SHAWN | JOHNS HOPKINS UNIVERSITY, MD | $2,190,123 | ZCA1 |
| 2024 | Specialized Program of Research Excellence (SPORE) in Leukemia2P50CA171963-11A1 · under PAR-20-305 | LINK, DANIEL C | WASHINGTON UNIVERSITY, MO | $2,109,864 | ZCA1 |
| 2024 | SPORE in Brain Cancer2P50CA127001-16 · under PAR-20-305 | FUEYO, JUANLANG, FREDERICK F | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,088,365 | ZCA1 |
| 2024 | SPORE in Cervical Cancer2P50CA098252-21 · under PAR-20-305 | HUH, WARNER KINGWU, TZYY-CHOOU | JOHNS HOPKINS UNIVERSITY, MD | $1,949,494 | ZCA1 |
| 2023 | DF/HCC Prostate SPORE1P50CA272390-01A1 · under PAR-20-305 | BALK, STEVEN P.BELTRAN, HIMISHA | DANA-FARBER CANCER INST, MA | $2,585,567 | ZCA1 |
| 2023 | The Pacific Northwest Prostate Cancer SPORE2P50CA097186-22 · under PAR-20-305 | NELSON, PETER S | FRED HUTCHINSON CANCER CENTER, WA | $2,398,516 | ZCA1 |
| 2023 | Route 66 Endometrial Cancer SPORE1P50CA265793-01A1 · under PAR-20-305 | BENBROOK, DORIS MANGIARACINALESLIE, KIMBERLY K.MUTCH, DAVID G | WASHINGTON UNIVERSITY, MO | $2,384,742 | ZCA1 |
| 2023 | Brain Tumor SPORE Grant2P50CA097257-21 · under PAR-20-305 | BERGER, MITCHEL S. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,316,634 | ZCA1 |
| 2023 | HCC Ovarian Cancer SPORE1P50CA272218-01A1 · under PAR-20-305 | BUCKANOVICH, RONALD JEDWARDS, ROBERT PAGE | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $2,163,827 | ZCA1 |
| 2023 | The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer1P50CA281701-01 · under PAR-20-305 | BAST, ROBERT CSOOD, ANIL K | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,144,148 | ZCA1 |
| 2023 | Molecularly Targeted Radiosensitization of Locally Advanced Cancers1P50CA269022-01A1 · under PAR-20-305 | LAWRENCE, THEODORE SMORGAN, MEREDITH A | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $2,066,150 | ZCA1 |
| 2023 | Washington University SPORE in Pancreatic Cancer1P50CA272213-01A1 · under PAR-20-305 | DENARDO, DAVID GFIELDS, RYAN C | WASHINGTON UNIVERSITY, MO | $2,065,042 | ZCA1 |
| 2023 | University of Wisconsin Prostate SPORE1P50CA269011-01A1 · under PAR-20-305 | JARRARD, DAVID F.MCNEEL, DOUGLAS G. | UNIVERSITY OF WISCONSIN-MADISON, WI | $2,061,062 | ZCA1 |
| 2023 | SPORE for Translational Approaches to Brain Cancer2P50CA221747-06 · under PAR-20-305 | LESNIAK, MACIEJ S | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $2,044,971 | ZCA1 |
| 2023 | Hawaii Minority Health and Cancer Disparities SPORE1P20CA275734-01A1 · under PAR-20-305 | BERENBERG, JEFFREY LEELE MARCHAND, LOIC | UNIVERSITY OF HAWAII AT MANOA, HI | $1,673,168 | ZCA1 |
| 2023 | Yale SPORE in Skin Cancer2P50CA121974-16 · under PAR-20-305 | BOSENBERG, MARCUS WKLUGER, HARRIET M. | YALE UNIVERSITY, CT | $1,533,274 | ZCA1 |
| 2022 | Dana Farber/Harvard Cancer Center SPORE in Lung Cancer1P50CA265826-01A1 · under PAR-20-305 | BARBIE, DAVID ASEQUIST, LECIA V. | DANA-FARBER CANCER INST, MA | $2,384,337 | ZCA1 |
| 2022 | SPORE in Prostate Cancer2P50CA092629-21A1 · under PAR-20-305 | CHEN, YUSCHER, HOWARD I | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,364,931 | ZCA1 |
| 2022 | The Memorial Sloan Kettering Cancer Center SPORE in Pancreas Cancer1P50CA257881-01A1 · under PAR-20-305 | O'REILLY, EILEEN MARY | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,329,651 | ZCA1 |
| 2022 | Mayo Clinic Breast Cancer SPORE2P50CA116201-16A1 · under PAR-20-305 | GOETZ, MATTHEW PHILIP | MAYO CLINIC ROCHESTER, MN | $2,317,281 | ZCA1 |
| 2022 | Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatment1P50CA272170-01 · under PAR-20-305 | SCHUETZE, SCOTT MICHAEL | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $2,282,833 | ZCA1 |
| 2022 | University of Texas Southwestern Medical Center SPORE in Kidney Cancer2P50CA196516-06A1 · under PAR-20-305 | BRUGAROLAS, JAMESKAPUR, PAYAL | UT SOUTHWESTERN MEDICAL CENTER, TX | $2,173,410 | ZCA1 |
| 2022 | Head and Neck Cancer SPORE2P50CA097190-16A1 · under PAR-20-305 | FERRIS, ROBERT L.SKINNER, HEATH DEVIN | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $2,138,140 | ZCA1 |
| 2022 | Selective Targeting of Pancreatic Cancer SPORE1P50CA257911-01A1 · under PAR-20-305 | YEH, JEN JEN | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $2,120,012 | ZCA1 |
| 2022 | SPORE in Lymphoma2P50CA126752-16 · under PAR-20-305 | BRENNER, MALCOLM K.HESLOP, HELEN E | BAYLOR COLLEGE OF MEDICINE, TX | $2,062,012 | ZCA1 |
| 2022 | UCLA SPORE in Brain Cancer2P50CA211015-06 · under PAR-20-305 | LIAU, LINDA M | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $2,046,459 | ZCA1 |
| 2022 | Head and Neck Cancer SPORE at the University of Wisconsin2P50CA278595-06A1 · under PAR-20-305 | HARARI, PAUL M | UNIVERSITY OF WISCONSIN-MADISON, WI | $2,028,647 | ZCA1 |
| 2021 | The Memorial Sloan Kettering Cancer Center SPORE in Leukemia1P50CA254838-01 · under PAR-18-313 | ABDEL-WAHAB, OMARTALLMAN, MARTIN S | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,350,964 | ZCA1 |
| 2021 | SPORE in Skin Cancer1P50CA261608-01 · under PAR-18-313 | AMARAVADI, RAVI KHERLYN, MEENHARD F | WISTAR INSTITUTE, PA | $2,323,912 | ZCA1 |
| 2021 | Epigenetic Therapies - New Approaches1P50CA254897-01A1 · under PAR-18-313 | BAYLIN, STEPHEN B.ISSA, JEAN-PIERRE J.JONES, PETER A | CORIELL INSTITUTE FOR MEDICAL RESEARCH, NJ | $2,269,729 | ZCA1 |
| 2021 | Developmental and Hyperactive Ras Tumor (DHART) SPORE2U54CA196519-06A1 · under PAR-18-313 | CLAPP, DAVID WSHANNON, KEVIN M. | INDIANA UNIVERSITY INDIANAPOLIS, IN | $2,198,683 | ZCA1 |
| 2021 | Mayo Clinic Multiple Myeloma SPORE2P50CA186781-06A1 · under PAR-18-313 | BERGSAGEL, PETER LEIF | MAYO CLINIC ARIZONA, AZ | $2,091,215 | ZCA1 |
| 2021 | Melanoma and Skin Cancer Program SPORE1P50CA254865-01A1 · under PAR-18-313 | KIRKWOOD, JOHN MUNNZAROUR, HASSANE M | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $2,037,632 | ZCA1 |
| 2021 | Colorado Head and Neck Cancer SPORE1P50CA261605-01 · under PAR-18-313 | JIMENO, ANTONIOWANG, XIAO-JING | UNIVERSITY OF COLORADO DENVER, CO | $1,968,453 | ZCA1 |
| 2021 | Mayo Clinic Ovarian Cancer SPORE2P50CA136393-11A1 · under PAR-18-313 | KAUFMANN, SCOTT H | MAYO CLINIC ROCHESTER, MN | $1,762,703 | ZCA1 |
| 2021 | Roswell Park Ovarian Cancer SPORE2P50CA159981-07A1 · under PAR-18-313 | MOYSICH, KIRSTEN B.ODUNSI, KUNLE | ROSWELL PARK CANCER INSTITUTE CORP, NY | $1,716,101 | ZCA1 |
| 2021 | SPORE in Prostate Cancer2P50CA180995-06A1 · under PAR-18-313 | ABDULKADIR, SARKI A.HUSSAIN, MAHA H | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $1,656,783 | ZCA1 |
| 2020 | DF/HCC Kidney Cancer SPORE2P50CA101942-16 · under PAR-18-313 | KAELIN, WILLIAM G.MCDERMOTT, DAVID | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $2,543,224 | ZCA1 |
| 2020 | Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant1P50CA240243-01A1 · under PAR-18-313 | D'ANDREA, ALAN D.MATULONIS, URSULA ANNESPRIGGS, DAVID R | DANA-FARBER CANCER INST, MA | $2,483,069 | ZCA1 |
| 2020 | Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer1P50DE030707-01 · under PAR-18-313 | BURTNESS, BARBARA | YALE UNIVERSITY, CT | $2,354,716 | ZCA1 |
| 2020 | MSK SPORE in Genomic Instability in Breast Cancer1P50CA247749-01 · under PAR-18-313 | POWELL, SIMON N. | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,257,697 | ZCA1 |
| 2020 | Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer2P50CA196530-06 · under PAR-18-313 | HERBST, ROY S | YALE UNIVERSITY, CT | $2,207,890 | ZCA1 |
| 2020 | Targeting Lung Cancer Vulnerabilities2P50CA070907-21A1 · under PAR-18-313 | HEYMACH, JOHN V.MINNA, JOHN D.ROTH, JACK | UT SOUTHWESTERN MEDICAL CENTER, TX | $2,203,273 | ZCA1 |
| 2020 | Translational Research in Breast Cancer2P50CA186784-06 · under PAR-18-313 | ELLIS, MATTHEW J | BAYLOR COLLEGE OF MEDICINE, TX | $2,137,830 | ZCA1 |
| 2019 | Fred Hutchinson Cancer Research Center Lung SPORE1P50CA228944-01A1 · under PAR-18-313 | HOUGHTON, A MCGARRY | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $2,491,191 | ZCA1 |
| 2019 | Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer2P50CA168504-06A1 · under PAR-18-313 | WINER, ERIC P | DANA-FARBER CANCER INST, MA | $2,482,574 | ZCA1 |
| 2019 | Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer2P50CA127003-11A1 · under PAR-18-313 | BASS, ADAM JOELEL-BARDEESY, NABEEL | DANA-FARBER CANCER INST, MA | $2,450,827 | ZCA1 |
| 2019 | SPORE: Targeted Therapies for Glioma2P50CA165962-06A1 · under PAR-18-313 | BATCHELOR, TRACY T | BRIGHAM AND WOMEN'S HOSPITAL, MA | $2,438,174 | ZCA1 |
| 2019 | Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer1P50CA236733-01 · under PAR-18-313 | COFFEY, ROBERT J. | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $2,368,006 | ZCA1 |
| 2019 | The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma1P50CA217674-01A1 · under PAR-18-313 | BERETTA, LAURAKASEB, AHMED | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,296,647 | ZCA1 |
| 2019 | SPORE in Multiple Myeloma2P50CA100707-16A1 · under PAR-18-313 | ANDERSON, KENNETH C.MUNSHI, NIKHIL C. | DANA-FARBER CANCER INST, MA | $2,276,698 | ZCA1 |
| 2019 | MD Anderson Cancer Center SPORE in Gastrointestinal Cancer1P50CA221707-01A1 · under PAR-18-313 | KOPETZ, SCOTTMAITRA, ANIRBAN | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,275,719 | ZCA1 |
| 2019 | SPORE in Breast Cancer2P50CA098131-17A1 · under PAR-18-313 | MAYER, INGRID APIETENPOL, JENNIFER A | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $2,218,149 | ZCA1 |
| 2019 | Duke SPORE in Brain Cancer2P50CA190991-06 · under PAR-18-313 | ALI-OSMAN, FRANCISSAMPSON, JOHN H. | DUKE UNIVERSITY, NC | $2,087,874 | ZCA1 |
| 2019 | The University of Texas MD Anderson Cancer Center SPORE in Melanoma1P50CA221703-01A1 · under PAR-18-313 | HWU, PATRICK | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,083,190 | ZCA1 |
| 2019 | SPORE in Brain Cancer2P50CA127001-11A1 · under PAR-18-313 | FUEYO, JUANLANG, FREDERICK F | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,069,263 | ZCA1 |
| 2019 | NYU Melanoma SPORE1P50CA225450-01A1 · under PAR-18-313 | OSMAN, IMANWEBER, JEFFREY S | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $2,063,466 | ZCA1 |
| 2019 | Emory University Lung Cancer SPORE1P50CA217691-01A1 · under PAR-18-313 | FU, HAIANRAMALINGAM, SURESH S | EMORY UNIVERSITY, GA | $1,853,913 | ZCA1 |
| 2019 | Michigan Prostate SPORE2P50CA186786-06 · under PAR-18-313 | CHINNAIYAN, ARUL MHEATH, ELISABETH ILJASPALAPATTU, GANESH S | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $1,783,426 | ZCA1 |
| 2019 | UCLA SPORE in Prostate Cancer2P50CA092131-16A1 · under PAR-18-313 | REITER, ROBERT E | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $1,708,652 | ZCA1 |
| 2019 | SPORE in Cervical Cancer2P50CA098252-16 · under PAR-18-313 | WU, TZYY-CHOOU | JOHNS HOPKINS UNIVERSITY, MD | $1,279,343 | ZCA1 |
| 2018 | City of Hope Lymphoma SPORE2P50CA107399-11A1 · under PAR-14-353 | FORMAN, STEPHEN JKWAK, LARRY W | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $2,500,000 | ZCA1 |
| 2018 | Yale SPORE in Skin Cancer2P50CA121974-11A1 · under PAR-14-353 | BOSENBERG, MARCUS WKLUGER, HARRIET M. | YALE UNIVERSITY, CT | $2,500,000 | ZCA1 |
| 2018 | SPORE in Gastrointestinal Cancers2P50CA062924-24A1 · under PAR-14-353 | KLEIN, ALISON P | JOHNS HOPKINS UNIVERSITY, MD | $2,500,000 | ZCA1 |
| 2018 | SPORE in Breast Cancer2P50CA058223-24A1 · under PAR-14-353 | EARP, H. SHELTONPEROU, CHARLES M | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $2,499,932 | ZCA1 |
| 2018 | Brain Tumor SPORE Grant2P50CA097257-16 · under PAR-14-353 | BERGER, MITCHEL S. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,498,496 | ZCA1 |
| 2018 | SPORE in Ovarian Cancer1P50CA228991-01 · under PAR-14-353 | SHIH, IE-MING | JOHNS HOPKINS UNIVERSITY, MD | $2,492,537 | ZCA1 |
| 2018 | Mayo Clinic Hepatobiliary SPORE1P50CA210964-01A1 · under PAR-14-353 | MC NIVEN, MARK A.ROBERTS, LEWIS R | MAYO CLINIC ROCHESTER, MN | $2,300,000 | ZCA1 |
| 2018 | SPORE for Translational Approaches to Brain Cancer1P50CA221747-01A1 · under PAR-14-353 | LESNIAK, MACIEJ S | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $2,300,000 | ZCA1 |
| 2018 | Specialized Program Of Research Excellence (SPORE) in Leukemia.2P50CA171963-06 · under PAR-14-353 | LINK, DANIEL C | WASHINGTON UNIVERSITY, MO | $2,299,839 | ZCA1 |
| 2018 | SPORE in Bladder Cancer1P50CA221745-01A1 · under PAR-14-353 | BAJORIN, DEAN F.SOLIT, DAVID B. | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,299,837 | ZCA1 |
| 2018 | SPORE in Soft Tissue Sarcoma1P50CA217694-01A1 · under PAR-14-353 | SINGER, SAMUEL | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,286,505 | ZCA1 |
| 2018 | The Pacific Northwest Prostate Cancer SPORE2P50CA097186-16A1 · under PAR-14-353 | NELSON, PETER S | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $2,157,062 | ZCA1 |
| 2018 | SPORE University of Texas M. D. Anderson Cancer Center-Leukemia2P50CA100632-16 · under PAR-14-353 | ISSA, JEAN-PIERRE J.KONOPLEVA, MARINA Y | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $1,392,864 | ZCA1 |
| 2017 | SPORE in Lymphoma2P50CA126752-11 · under PAR-14-353 | BRENNER, MALCOLM K.HESLOP, HELEN E | BAYLOR COLLEGE OF MEDICINE, TX | $3,097,657 | ZCA1 |
| 2017 | Case GI SPORE2P50CA150964-06A1 · under PAR-14-353 | MARKOWITZ, SANFORD D. | CASE WESTERN RESERVE UNIVERSITY, OH | $2,375,000 | ZCA1 |
| 2017 | Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer2P50CA097274-16 · under PAR-14-353 | WEINER, GEORGE J.WITZIG, THOMAS E. | UNIVERSITY OF IOWA, IA | $2,375,000 | ZCA1 |
| 2017 | SPORE in Myeloid Malignancies1P50CA206963-01A1 · under PAR-14-353 | EBERT, BENJAMIN LEVINESTONE, RICHARD M | BRIGHAM AND WOMEN'S HOSPITAL, MA | $2,185,000 | ZCA1 |
| 2017 | UCLA SPORE in Brain Cancer1P50CA211015-01A1 · under PAR-14-353 | LIAU, LINDA M | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $2,185,000 | ZCA1 |
| 2017 | Weill Cornell Medicine (WCM) SPORE in Prostate Cancer1P50CA211024-01A1 · under PAR-14-353 | RUBIN, MARK A. | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $2,184,999 | ZCA1 |
| 2017 | U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer1P50CA217685-01 · under PAR-14-353 | BAST, ROBERT CSOOD, ANIL K | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $1,732,856 | ZCA1 |
| 2016 | Mayo Clinic Breast Cancer SPORE2P50CA116201-11 · under PAR-14-353 | GOETZ, MATTHEW PHILIPINGLE, JAMES NEWELL | MAYO CLINIC ROCHESTER, MN | $2,350,000 | ZCA1 |
| 2016 | SPORE in Prostate Cancer2P50CA092629-16 · under PAR-14-353 | SCHER, HOWARD I | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,349,999 | ZCA1 |
| 2016 | MD Anderson Cancer Center Prostate Cancer SPORE2P50CA140388-06A1 · under PAR-14-353 | LOGOTHETIS, CHRISTOPHER J.THOMPSON, TIMOTHY CHARLES | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,259,759 | ZCA1 |
| 2016 | Washington University SPORE in Pancreatic Cancer1P50CA196510-01A1 · under PAR-14-353 | HAWKINS, WILLIAM G | WASHINGTON UNIVERSITY, MO | $2,186,724 | ZCA1 |
| 2016 | Head and Neck Cancer SPORE at the University of Wisconsin1P50DE026787-01A1 · under PAR-14-353 | HARARI, PAUL M | UNIVERSITY OF WISCONSIN-MADISON, WI | $2,170,679 | ZCA1 |
| 2016 | MSK SPORE in Lymphoma1P50CA192937-01A1 · under PAR-14-353 | YOUNES, ANASZELENETZ, ANDREW D. | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,162,000 | ZCA1 |
| 2016 | The University of Texas Southwestern Medical Center SPORE in Kidney Cancer1P50CA196516-01A1 · under PAR-14-353 | BRUGAROLAS, JAMES | UT SOUTHWESTERN MEDICAL CENTER, TX | $2,162,000 | ZCA1 |
| 2016 | MD Anderson Gynecologic SPORE for Uterine Cancers2P50CA098258-11A1 · under PAR-14-353 | BROADDUS, RUSSELL RLU, KAREN HSIEH | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,162,000 | ZCA1 |
| 2015 | Developmental and HyperActive Ras Tumor SPORE1U54CA196519-01 · under PAR-14-031 | CLAPP, DAVID WSHANNON, KEVIN M. | INDIANA UNIVERSITY INDIANAPOLIS, IN | $2,384,507 | ZCA1 |
| 2015 | Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer1P50CA174521-01A1 · under PAR-14-031 | O'DORISIO, M. SUE | UNIVERSITY OF IOWA, IA | $2,185,000 | ZCA1 |
| 2015 | Mayo Clinic Multiple Myeloma SPORE1P50CA186781-01A1 · under PAR-14-031 | BERGSAGEL, PETER LEIF | MAYO CLINIC ARIZONA, AZ | $2,185,000 | ZCA1 |
| 2015 | Head and Neck Cancer SPORE2P50CA097190-11 · under PAR-14-031 | FERRIS, ROBERT L.GRANDIS, JENNIFER RUBIN | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $2,185,000 | ZCA1 |
| 2015 | Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer1P50CA196530-01 · under PAR-14-031 | HERBST, ROY S | YALE UNIVERSITY, CT | $2,185,000 | ZCA1 |
| 2015 | DF/HCC Kidney Cancer SPORE2P50CA101942-11A1 · under PAR-14-031 | KAELIN, WILLIAM G.MCDERMOTT, DAVID | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $2,185,000 | ZCA1 |
| 2015 | SPORE in Prostate Cancer1P50CA180995-01A1 · under PAR-14-031 | CATALONA, WILLIAM J | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $2,185,000 | ZCA1 |
| 2015 | Mayo Clinic Ovarian Cancer SPORE2P50CA136393-06A1 · under PAR-14-031 | KAUFMANN, SCOTT H | MAYO CLINIC ROCHESTER, MN | $2,184,999 | ZCA1 |
| 2014 | SPORE in Skin Cancer1P50CA174523-01A1 · under PAR-12-296 | HERLYN, MEENHARD F | WISTAR INSTITUTE, PA | $2,162,000 | ZCA1 |
| 2014 | SPORE in Lung Cancer2P50CA058187-19A1 · under PAR-12-296 | BUNN, PAUL A. | UNIVERSITY OF COLORADO DENVER, CO | $2,162,000 | ZCA1 |
| 2014 | Translational Research in Breast Cancer (SPORE)1P50CA186784-01 · under PAR-12-296 | OSBORNE, C KENT | BAYLOR COLLEGE OF MEDICINE, TX | $2,162,000 | ZCA1 |
| 2014 | SPORE in Pancreatic Cancer2P50CA127297-06A1 · under PAR-12-296 | HOLLINGSWORTH, MICHAEL A. | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $2,162,000 | ZCA1 |
| 2014 | Mayo Clinic SPORE in Pancreatic Cancer2P50CA102701-11A1 · under PAR-12-296 | PETERSEN, GLORIA M. | MAYO CLINIC ROCHESTER, MN | $2,162,000 | ZCA1 |
| 2014 | SPORE in Prostate Cancer1P50CA186786-01 · under PAR-12-296 | CHINNAIYAN, ARUL M | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $2,162,000 | ZCA1 |
| 2014 | SPORE in Cervical Cancer2P50CA098252-11 · under PAR-12-296 | WU, TZYY-CHOOU | JOHNS HOPKINS UNIVERSITY, MD | $2,162,000 | ZCA1 |
| 2014 | Duke SPORE in Brain Cancer1P50CA190991-01 · under PAR-14-031 | ALI-OSMAN, FRANCISSAMPSON, JOHN H. | DUKE UNIVERSITY, NC | $2,162,000 | ZCA1 |
| 2014 | SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer2P50CA070907-16A1 · under PAR-12-296 | MINNA, JOHN D.ROTH, JACK | UT SOUTHWESTERN MEDICAL CENTER, TX | $2,161,999 | ZCA1 |
| 2014 | SPORE in Thyroid Cancer1P50CA172012-01A1 · under PAR-12-296 | FAGIN, JAMES A | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,008,466 | ZCA1 |
| 2014 | SPORE in Prostate Cancer2P50CA058236-19A1 · under PAR-12-296 | NELSON, WILLIAM GEORGE | JOHNS HOPKINS UNIVERSITY, MD | $1,877,328 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.